Luke M. Beshar, Director at Protara Therapeutics, Inc. (TARA), bought 10,000 shares at $4.46 ($45K) on 2022-03-10, disclosed to the SEC on 2022-03-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| RGNX | SELL | 2018-12-03 | $831K | — | Filing → |
| RGNX | SELL | 2018-11-28 | $2.6M | — | Filing → |
| RGNX | SELL | 2018-11-21 | $3.9M | — | Filing → |